Early MS Treatments Impact Relapses And Brain Scarring Differently, But Not Disability
FRIDAY, Oct. 16, 2026— Therapy targeting the immune system’s B cells might offer better odds against relapses in the early stages of multiple sclerosis (MS), a new study reports.People taking IV drugs that lower immune B-cell levels had a 62%...
Read more »
Pharmaceutical news
Ultra-Processed Foods Linked To Hidden Brain Damage And Stroke Risk
Poorer Maternal Diet Quality Linked to Infantile Colic, Eczema
Adverse Family Outcomes Reported for Children With B-Cell ALL
Intermittent Hemodialysis Not Noninferior to Continuous Renal-Replacement Therapy
Occupational Standing, Walking, Bending Linked to Risk for Miscarriage
Demographic, Tumor Factors Linked to Delays in Breast Cancer Care in Young Women
High Viral Suppression Found for Patients With HIV Receiving Long-Acting LEN/CAB
Imaging-Based Modalities Compared for Identifying At-Risk MASH
Is Hormone Therapy Right For Menopause Symptoms? OB-GYNs Are Offering These More Detailed Guidelines
Napping Linked To Dementia Risk
Taking Antipsychotics? Diabetes Risk Runs High In First Few Months, Study Warns
Most Seniors Don't Bother Researching Their Medicare Options, Poll Finds
1990 to 2023 Saw Increase in Global Burden of Acne
Structured Support May Attenuate Weight Gain After GLP-1 RA Cessation
